1. Home
  2. Analysis

Coronary arterial stent insertion and drugs of ingredients of cobalamin (a real world drug study)


Summary:

Coronary arterial stent insertion is found among people who take drugs with ingredients of cobalamin, especially for people who are male, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 119,655 people who have side effects when taking drugs with ingredients of cobalamin from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): B-12, B12, Vitamin b12.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

119,655 people reported to have side effects when taking drugs with ingredients of cobalamin.
Among them, 43 people (0.04%) have Coronary arterial stent insertion

What is Coronary arterial stent insertion?

Coronary arterial stent insertion is found to be associated with 370 drugs and 490 conditions by eHealthMe. Check the latest studies of Coronary arterial stent insertion.

Number of reports submitted per year:

Could drugs with ingredients of cobalamin cause Coronary arterial stent insertion?

Gender of people who have Coronary arterial stent insertion when taking drugs with ingredients of cobalamin *:

  • female: 45.24 %
  • male: 54.76 %

Age of people who have Coronary arterial stent insertion when taking drugs with ingredients of cobalamin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 16.67 %
  • 60+: 83.33 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 11 people, 25.58%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 11.63%
  3. High Blood Pressure: 3 people, 6.98%
  4. Diabetes: 3 people, 6.98%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 6.98%
  6. Pain: 3 people, 6.98%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.65%
  8. High Blood Cholesterol: 2 people, 4.65%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 4.65%
  10. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 4.65%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Plavix: 13 people, 30.23%
  2. Vitamin D3: 9 people, 20.93%
  3. Aspirin: 9 people, 20.93%
  4. Clopidogrel: 9 people, 20.93%
  5. Oxycodone: 7 people, 16.28%
  6. Humira: 7 people, 16.28%
  7. Lipitor: 7 people, 16.28%
  8. Prednisone: 6 people, 13.95%
  9. Lantus: 6 people, 13.95%
  10. Amlodipine: 5 people, 11.63%

Other side effects people have besides Coronary arterial stent insertion *:

You may use this to check any potential undetected side effects.

  1. Nausea (feeling of having an urge to vomit): 11 people, 25.58%
  2. Dyspnea (difficult or laboured breathing): 10 people, 23.26%
  3. High Blood Pressure: 8 people, 18.60%
  4. Cough: 6 people, 13.95%
  5. Oxygen Saturation Decreased: 6 people, 13.95%
  6. Chest Pain: 5 people, 11.63%
  7. Dizziness: 5 people, 11.63%
  8. Fever: 5 people, 11.63%
  9. Weight Decreased: 4 people, 9.30%
  10. Abdominal Pain Upper: 4 people, 9.30%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of cobalamin, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on cobalamin. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.